share_log

Akanda Corp Announces Settlement Agreement With Former CEO Tejinder Virk

Akanda Corp Announces Settlement Agreement With Former CEO Tejinder Virk

阿坎達公司宣佈與前首席執行官Tejinder Virk達成和解協議
newsfile ·  05/13 17:26

London, United Kingdom--(Newsfile Corp. - May 13, 2024) - Akanda Corp. (NASDAQ: AKAN) ("Akanda" or the "Company"), today announced a settlement agreement with former chief executive officer and director, Tejinder Virk, concluding a series of disputes that commenced following Mr. Virk's resignation on February 3, 2023.

英國倫敦--(Newsfile Corp.,2024年5月13日)——阿坎達公司(納斯達克股票代碼:AKAN)(“阿坎達” 或 “公司”)今天宣佈與前首席執行官兼董事泰金德·維爾克達成和解協議,結束了自維爾克於2023年2月3日辭職後開始的一系列爭議。

The settlement resolves all outstanding claims and disputes Mr. Virk had with the Company and its subsidiaries, providing a clear path forward and allowing all parties to focus on their future endeavors without the overhang of previous disagreements.

該和解協議解決了維爾克先生與公司及其子公司的所有未決索賠和爭議,提供了明確的前進方向,使各方能夠專注於未來的工作,而不會因先前的分歧而懸而未決。

Katharyn Field, Chief Executive Officer of Akanda Corp, commented, "Our decision to settle is in the best interest of everyone involved. It allows us to continue dedicating our resources and attention to strategic priorities without distraction."

阿坎達公司首席執行官凱瑟琳·菲爾德評論說:“我們的和解決定符合所有相關人員的最大利益。它使我們能夠繼續將資源和精力投入到戰略優先事項上,而不會分散注意力。”

The agreement includes a waiver of all claims related to Mr. Virk's employment and its termination. Any queries relating to the settlement should be addressed to the Company's UK counsel, Paul McAleavey of Girlings Solicitors LLP.

該協議包括豁免與維爾克先生的僱用及其解僱有關的所有索賠。與和解有關的任何疑問均應向該公司的英國法律顧問、Girlings Solicitors LLP的保羅·麥卡利維提出。

About Akanda Corp.

關於阿坎達公司

Akanda is an international medical cannabis and wellness platform company seeking to help people lead better lives through improved access to high quality and affordable products. Akanda's portfolio includes CanMart, a UK-based fully licensed pharmaceutical importer and distributor which supplies pharmacies and clinics within the UK. The Company's seed-to-patient supply chain also includes partnerships Cellen Life Sciences' Leva Clinic, one of the first fully digital pain clinics in the UK. Akanda also acquired the right to develop a Canadian farming property in British Columbia, including farming land and related operations and licenses. The Company plans to develop THC and cannabinoid (CBD) facilities at this site.

Akanda是一家國際醫用大麻和健康平台公司,旨在通過改善獲得高質量和負擔得起的產品的機會,幫助人們過上更好的生活。阿坎達的投資組合包括CanMart,這是一家總部位於英國的全牌藥品進口商和分銷商,爲英國境內的藥房和診所提供服務。該公司的從種子到患者的供應鏈還包括合作伙伴Cellen Life Sciences的Leva Clinic,這是英國首批完全數字化的疼痛診所之一。阿坎達還獲得了在不列顛哥倫比亞省開發加拿大農業地產的權利,包括耕地和相關運營和許可證。該公司計劃在該地點開發四氫大麻酚和大麻素(CBD)設施。

Connect with Akanda: Email | Website | LinkedIn | Twitter | Instagram

聯繫 Akanda:電子郵件 | 網站 | LinkedIn | Twitter | Instagram

Investor Contact

投資者聯繫人

ir@akandacorp.com

ir@akandacorp.com

Cautionary Note Regarding Forward-Looking Information and Statements

關於前瞻性信息和陳述的警示說明

This press release contains certain "forward-looking information" within the meaning of the safe harbor provisions of the United States Private Securities Litigation Reform Act of 1995. Such forward-looking information and forward-looking statements are not representative of historical facts or information or current condition, but instead represent only Akanda's beliefs regarding future events, plans or objectives, many of which, by their nature, are inherently uncertain and outside of Akanda's control. Generally, such forward-looking information or forward-looking statements can be identified by the use of forward-looking terminology such as "plans", "expects" or "does not expect", "is expected", "budget", "scheduled", "estimates", "forecasts", "intends", "anticipates" or "does not anticipate", or "believes", or variations of such words and phrases or may contain statements that certain actions, events or results "may", "could", "would", "might" or "will be taken", "will continue", "will occur" or "will be achieved" and similar expressions and include statements regarding the timing and completion of the proposed offering. Forward-looking information may relate to anticipated events or results including, but not limited to business strategy, product development and sales and growth plans. The forward-looking information and forward-looking statements contained in this press release are made as of the date of this press release, and Akanda does not undertake to update any forward-looking information and/or forward-looking statements that are contained or referenced herein, except in accordance with applicable securities laws.

本新聞稿包含1995年《美國私人證券訴訟改革法》安全港條款所指的某些 “前瞻性信息”。此類前瞻性信息和前瞻性陳述不能代表歷史事實或信息或當前狀況,而僅代表阿坎達對未來事件、計劃或目標的信念,其中許多事情、計劃或目標本質上是不確定的,不在阿坎達的控制範圍內。通常,此類前瞻性信息或前瞻性陳述可以通過使用前瞻性術語來識別,例如 “計劃”、“預期” 或 “不預期”、“預算”、“預期”、“估計”、“打算”、“預期” 或 “不相信”,或此類詞語和短語的變體或可能包含某些行爲、事件或結果 “可能” 的陳述、“可以”、“將”、“可能” 或 “將被採取”、“將繼續”、“將發生” 或 “將實現” 以及類似的表述幷包括聲明關於擬議發行的時間和完成情況。前瞻性信息可能與預期事件或結果有關,包括但不限於業務戰略、產品開發以及銷售和增長計劃。本新聞稿中包含的前瞻性信息和前瞻性陳述自本新聞稿發佈之日起作出,除非根據適用的證券法,否則阿坎達不承諾更新此處包含或引用的任何前瞻性信息和/或前瞻性陳述。

声明:本內容僅用作提供資訊及教育之目的,不構成對任何特定投資或投資策略的推薦或認可。 更多信息
    搶先評論